Human Umbilical Cord Mesenchymal Stem Cells ( DrugBank: Human Umbilical Cord Mesenchymal Stem Cells )

3 diseases

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01364246 (ClinicalTrials.gov)	January 2010	31/5/2011	Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica	Phase I/II Study of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Progressive Multiple Sclerosis and Neuromyelitis Optica	Progressive Multiple Sclerosis;Neuromyelitis Optica.	Biological: human umbilical cord mesenchymal stem cells	Shenzhen Beike Bio-Technology Co., Ltd.	The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School;The Affiliated Nanjing Brain Hospital of Nanjing University Medical School;Nanjing University Medical College Affiliated Wuxi Second Hospital;Xuzhou Medical College;The Second Hospital of Nanjing Medical University	Recruiting	18 Years	60 Years	Both	20	Phase 1/Phase 2	China

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05262829 (ClinicalTrials.gov)	February 28, 2022	8/2/2022	Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease	A Single-arm, Open-label Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Refractory Moderate to Severe Crohn's Disease	Crohn Disease	Biological: Human Umbilical Cord Mesenchymal Stem Cells	Shanghai East Hospital	NULL	Recruiting	18 Years	70 Years	All	40	N/A	China
2	NCT05039411 (ClinicalTrials.gov)	January 1, 2022	1/9/2021	Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas Patients With Crohn's Disease	A Phase I Study of the Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) for Perianal Fistulas in Patients With Crohn's Disease	Perianal Fistula Due to Crohn's Disease;Fistula in Ano	Biological: Human umbilical cord mesenchymal stem cells (UC-MSCs)	CryoCord Sdn Bhd	University of Malaya	Not yet recruiting	18 Years	N/A	All	7	Phase 1	Malaysia

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02235844 (ClinicalTrials.gov)	September 2014	8/9/2014	Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)	Allogeneic Transplantation of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) for a Single Male Patient With Duchenne Muscular Dystrophy (DMD)	Duchenne's Muscular Dystrophy	Biological: Umbilical Cord Mesenchymal Stem Cells	Allergy and Asthma Consultants, Wichita, Kansas	Aidan Foundation;Neil H. Riordan PhD	Completed	28 Years	31 Years	Male	1	Phase 1	United States
2	NCT01610440 (ClinicalTrials.gov)	October 2011	21/5/2012	Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Therapy for Patients With Duchenne Muscular Dystrophy	Phase I/II Study of Stem Cell Therapy in Patients With Duchenne Muscular Dystrophy	Duchenne Muscular Dystrophy	Biological: human umbilical cord mesenchymal stem cells	Shenzhen Beike Bio-Technology Co., Ltd.	The Second Affiliated Hospital of Kunming Medical University	Recruiting	5 Years	12 Years	Both	15	Phase 1/Phase 2	China